» Articles » PMID: 31245788

Metabolic Signatures of Cancer Cells and Stem Cells

Overview
Journal Nat Metab
Publisher Springer Nature
Specialty Endocrinology
Date 2019 Jun 28
PMID 31245788
Citations 144
Authors
Affiliations
Soon will be listed here.
Abstract

In contrast to terminally differentiated cells, cancer cells and stem cells retain the ability to re-enter the cell cycle and proliferate. In order to proliferate, cells must increase the uptake and catabolism of nutrients to support anabolic cell growth. Intermediates of central metabolic pathways have emerged as key players that can influence cell differentiation 'decisions', processes relevant for both oncogenesis and normal development. Consequently, how cells rewire metabolic pathways to support proliferation may have profound consequences for cellular identity. Here, we discuss the metabolic programs that support proliferation and explore how metabolic states are intimately entwined with the cell fate decisions that characterize stem cells and cancer cells. By comparing the metabolism of pluripotent stem cells and cancer cells, we hope to illuminate common metabolic strategies as well as distinct metabolic features that may represent specialized adaptations to unique cellular demands.

Citing Articles

Metaboloepigenetics: Role in the Regulation of Flow-Mediated Endothelial (Dys)Function and Atherosclerosis.

Santos F, Sum H, Yan D, Brewer A Cells. 2025; 14(5).

PMID: 40072106 PMC: 11898952. DOI: 10.3390/cells14050378.


Sirt6 loss activates Got1 and facilitates cleft palate through abnormal activating glycolysis.

Wang X, Zhao X, Zheng X, Peng X, Chen J, Wang Y Cell Death Dis. 2025; 16(1):159.

PMID: 40050262 PMC: 11885815. DOI: 10.1038/s41419-025-07465-8.


Chlorogenic acid promotes fatty acid beta-oxidation to increase hESCs proliferation and lipid synthesis.

Zong M, Ji J, Wang Q, Cai Y, Chen L, Zhang L Sci Rep. 2025; 15(1):7095.

PMID: 40016322 PMC: 11868603. DOI: 10.1038/s41598-025-91582-z.


Hsp90α promotes lipogenesis by stabilizing FASN and promoting FASN transcription via LXRα in hepatocellular carcinoma.

Deng Z, Liu L, Xie G, Zheng Z, Li J, Tan W J Lipid Res. 2024; 66(1):100721.

PMID: 39645039 PMC: 11745951. DOI: 10.1016/j.jlr.2024.100721.


IDH Mutations in Glioma: Molecular, Cellular, Diagnostic, and Clinical Implications.

Choate K, Pratt E, Jennings M, Winn R, Mann P Biology (Basel). 2024; 13(11).

PMID: 39596840 PMC: 11592129. DOI: 10.3390/biology13110885.


References
1.
Beaudin A, Stover P . Insights into metabolic mechanisms underlying folate-responsive neural tube defects: a minireview. Birth Defects Res A Clin Mol Teratol. 2009; 85(4):274-84. PMC: 4435943. DOI: 10.1002/bdra.20553. View

2.
Luengo A, Gui D, Vander Heiden M . Targeting Metabolism for Cancer Therapy. Cell Chem Biol. 2017; 24(9):1161-1180. PMC: 5744685. DOI: 10.1016/j.chembiol.2017.08.028. View

3.
Kong H, Chandel N . Regulation of redox balance in cancer and T cells. J Biol Chem. 2017; 293(20):7499-7507. PMC: 5961053. DOI: 10.1074/jbc.TM117.000257. View

4.
Chantranupong L, Wolfson R, Sabatini D . Nutrient-sensing mechanisms across evolution. Cell. 2015; 161(1):67-83. PMC: 4384161. DOI: 10.1016/j.cell.2015.02.041. View

5.
Schvartzman J, Thompson C, Finley L . Metabolic regulation of chromatin modifications and gene expression. J Cell Biol. 2018; 217(7):2247-2259. PMC: 6028552. DOI: 10.1083/jcb.201803061. View